Fig. 2From: Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trialFrequency of CD8+ and CD4+ lymphocytes during treatment. a: Boxplot comparing the frequency of CD8+ lymphocytes at baseline, before start of SBRT and at the first evaluation visit. b: Boxplot comparing the frequency of CD4+ lymphocytes at baseline, before start of SBRT and at the first evaluation visitBack to article page